Open AccessAzole-Resistant Aspergillus and Echinocandin-Resistant Candida: What Are the Treatment Options?
Author(s) -
Alison R. Novak,
Mary E. Bradley,
Tyree H. Kiser,
Scott W. Mueller
Publication year - 2020
Publication title -
current fungal infection reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 24
eISSN - 1936-377X
pISSN - 1936-3761
DOI - 10.1007/s12281-020-00379-2
Subject(s) - echinocandin , posaconazole , azole , echinocandins , amphotericin b , intensive care medicine , aspergillus fumigatus , aspergillosis , medicine , antifungal , caspofungin , biology , fluconazole , microbiology and biotechnology , immunology
This review summarizes current treatment options for echinocandin-resistant Candida spp. (ERC) and azole-resistant Aspergillus fumigatus (ARAF), emphasizing recent in vitro/in vivo data, clinical reports, and consensus statements.